PCC Funded COMPASS Trial Leads to the Discovery of Five New Subtypes of Pancreatic Cancer We are excited to share the recent success of the COMPASS trial, a research study funded in part by Pancreatic Cancer Canada, that has announced the discovery of five distinct...
Dr. Anish Kirpalani, Pancreatic Cancer Canada’s board chair and a radiologist with 10 years of practice experience in Canada and the US, discusses the issues surrounding this most challenging form of cancer with Jane Brown on Zoomer Radio. Listen to the...
Compete For the Cure™: A Story of Champions When Lauren was in grade eight her father, Dr. Michael Clarfield, was diagnosed with pancreatic cancer. Faced with the one of world’s toughest cancers, Michael and his family put up a hard fight and were relieved when they...
Research Investments: 2018 After investing in genetic sequencing in 2017, we realized we were just scratching the surface: both in terms of our understanding of pancreatic cancer subtypes, but also in the ways that personalized medicine – which involves...
Research Investments: 2017 2017 marked our first year investing in the most cutting-edge research from coast to coast under our PancOne™ research network. We built a new advisory board who helped us focus our research investments to what was going to make the biggest...
Research Investments: 2016 2016 was an important year for Pancreatic Cancer Canada and the direction of our research investments. We fulfilled research commitments as part of our Pancreatic Cancer Canada Innovation Grants program, invested in new equipment that aids...
Recent Comments